---
title: "Weekly Recap | ADPT.US -0.33%, most brokers rate it buy"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298799062.md"
description: "ADPT.US slipped 0.33% this week to close at $24.20, outperforming the S&P 500, which fell 0.8%. Trading was range-bound: after opening at $23.98 on Tuesday, the stock edged higher through midweek, dipped to $23.53 on Thursday, and then faded from a Friday high of $24.79 to end nearly flat versus the prior Friday. There was no major catalyst, and average daily volume of about 1.19m shares sat well below the 60-day median of roughly 2.39m."
datetime: "2026-09-12T07:40:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298799062.md)
  - [en](https://longbridge.com/en/news/298799062.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298799062.md)
generator: "portal-rs"
---

# Weekly Recap | ADPT.US -0.33%, most brokers rate it buy

## The Week

ADPT.US slipped 0.33% this week to close at $24.20, outperforming the S&P 500, which fell 0.8%. Trading was range-bound: after opening at $23.98 on Tuesday, the stock edged higher through midweek, dipped to $23.53 on Thursday, and then faded from a Friday high of $24.79 to end nearly flat versus the prior Friday. There was no major catalyst, and average daily volume of about 1.19m shares sat well below the 60-day median of roughly 2.39m.

## Analyst Ratings

Eight firms cover ADPT.US: five rate it a buy, two overweight, and one hold, with no underweight or sell ratings. The consensus rating is buy, with a consensus target of $25.07, about 3.6% above the latest price. Targets range from $21.00 to $28.00, a roughly $7 spread that points to moderate dispersion. The stock ranks 27th out of 54 names in the life-science tools and services industry.

## The Week Ahead

On the macro front, the New York Fed manufacturing index lands Tuesday (prior 20.6, consensus 14.75), followed by Wednesday’s retail sales figures (prior -0.6, consensus 0.9), which could shift risk appetite for biotech. No company-specific earnings are scheduled, so the watch items are whether this week’s light volume persists and how price behaves around the $25 level and the 20-day moving average.

*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [ADPT.US](https://longbridge.com/en/quote/ADPT.US.md)

## Related News & Research

- [Adaptogenics Health Corp. (ADPT) Closes $327K Private Placement at $0.08](https://longbridge.com/en/news/300347211.md)
- [Adaptive Biotechnologies consensus price target increased by 11.11% to $28.05](https://longbridge.com/en/news/300759288.md)
- [ServiceNow (NOW) Dropped, What Is Behind the Fresh Attention?](https://longbridge.com/en/news/300869156.md)
- [Western Digital vs. Sandisk: The Better Way to Play the Hard-Drive Side of the AI Storage Boom](https://longbridge.com/en/news/300870855.md)
- [Greg Abel-Led Berkshire Hathaway Owns 3 Consumer Stocks. Here's the One I'd Buy First.](https://longbridge.com/en/news/300873098.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**